Narrow search
Showing 1 - 10 of 2,653
Cover Image
A new indicator to implement effective spending review policies in the public procurement for standardized goods
Leverano, Adriano de; Baulia, Susmita - 2023
We suggest an alternative indicator that can lead to price reductions in the public procurement market for goods, i.e., the elasticity of prices to quantities purchased. We apply the analysis to the procurement of medical devices by exploiting a survey from the Italian AntiCorruption Authority....
Persistent link: https://www.econbiz.de/10014472293
Cover Image
Pharmaceutical regulation and health policy objectives
Birg, Laura - 2013
system results in lower health expenditure, but higher financial exposure of patients. Total welfare is higher under the …
Persistent link: https://www.econbiz.de/10010224844
Cover Image
The European Health Data Space
Marcus, J. Scott; Martens, Bertin; Carugati, Christophe; … - 2022
This study for the European Parliament Policy Department examines the regulation for a European Health Data Space (EHDS …), proposed by the European Commission in May 2022. The EHDS introduces mandatory rules for electronic health record to facilitate … user access and portability of personal health data (primary use) and pooling of health data for research and policy …
Persistent link: https://www.econbiz.de/10014256340
Cover Image
Patient mobility, health care quality and welfare
Brekke, Kurt R.; Levaggi, Rosella; Siciliani, Luigi; … - 2014
on health care quality, health care financing and welfare. We show that without patient mobility quality is too low (high …
Persistent link: https://www.econbiz.de/10010229860
Cover Image
Excessive Pharmaceutical Prices and Competition Law : Doctrinal Development to Protect Public Health
Abbott, Frederick M. - 2017
Public health budgets and ... …
Persistent link: https://www.econbiz.de/10012970248
Cover Image
Free Movement and Competition in the European Market for Pharmaceuticals
Caro de Sousa, Pedro - 2016
Very few industries are as profoundly influenced by regulation as the pharmaceutical industry. All aspects of the life-cycle of new drugs are regulated, from patent application, to marketing approval, commercial exploitation, patent expiration and competition with generics. The nature of demand...
Persistent link: https://www.econbiz.de/10012980141
Cover Image
The Problems Created by the Rising Food Prices and Prices for Other Vital Goods During the Current Pandemic
Levashenko, Antonina; Girich, Maris - 2020
During the COVID-19 pandemic, prices for a number of consumer goods and services, as well as for some pharmaceutical and medicines products, have increased significantly. To counter the attempts of unscrupulous sellers to increase their profits by price gouging, the governments of several OECD...
Persistent link: https://www.econbiz.de/10014096077
Cover Image
Patient Mobility, Health Care Quality and Welfare
Brekke, Kurt Richard; Levaggi, Rosella; Siciliani, Luigi; … - 2021
on health care quality, health care financing and welfare. We show that without patient mobility quality is too low (high …
Persistent link: https://www.econbiz.de/10013315635
Cover Image
Are the fiscal flows of the European Union budget explainable by distributional criteria?
Hayo, Bernd - 1996
Persistent link: https://www.econbiz.de/10013418618
Cover Image
Fiscal capacity and social protection expenditure in developing nations
Murshed, Syed Mansoob; Badiuzzaman, Muhammad; Pulok, … - 2017
There is scant analysis on the causal relationship between fiscal capacity and social protection expenditure in the developing world. We investigate the causal relationship between fiscal capacity of the state and social protection expenditure, hypothesizing that fiscal capacity is necessary but...
Persistent link: https://www.econbiz.de/10011627695